Atlas Trials

Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers

Clinical trial NCT00895102 · COMPLETED

Trial details

NCT number
NCT00895102
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HCV Infection
Start date
2009-04-01
Primary completion
2009-06-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.